Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Richman, Sara
109  Ergebnisse:
Personensuche X
?
1

Equipment Qualification:

, In: Cell Therapy,
Richman, Sara - p. 417-423 , 2021
Link: https://doi.org/10.1007/..
 
?
2

A Phase II study of autologous mesenchymal stromal cells an..:

Bolli, Roberto ; Mitrani, Raul D. ; Hare, Joshua M....
European Journal of Heart Failure.  23 (2021)  4 - p. 661-674 , 2021
Link: https://doi.org/10.1002/..
 
?
3

Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induce..:

Bolli, Roberto ; Perin, Emerson C. ; Willerson, James T....
JACC: CardioOncology.  2 (2020)  4 - p. 581-595 , 2020
Link: https://doi.org/10.1016/..
 
?
4

Analysis of transient warming events for gene modified viru..:

Lapteva, Natalia ; Gilbert, Margaret ; Bloom, Jeannette...
Cytotherapy.  19 (2017)  5 - p. e16 , 2017
Link: https://doi.org/10.1016/..
 
?
5

Factors affecting the turnaround time for manufacturing, te..:

Richman, Sara ; Gee, Adrian P. ; McKenna, David H....
Transfusion.  52 (2012)  10 - p. 2225-2233 , 2012
Link: https://doi.org/10.1111/..
 
?
6

Multicenter cell processing for cardiovascular regenerative..:

Gee, Adrian P. ; Richman, Sara ; Durett, April...
Cytotherapy.  12 (2010)  5 - p. 684-691 , 2010
Link: https://doi.org/10.3109/..
 
?
7

A Phase II study of autologous mesenchymal stromal cells an..:

Bolli, Roberto ; Mitrani, Raul D ; Hare, Joshua M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357352/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
8

A Phase II study of autologous mesenchymal stromal cells an..:

Bolli, Roberto ; Mitrani, Raul D ; Hare, Joshua M...
qt8m02m3zx.  , 2021
Link: https://escholarship.org..
 
?
9

Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induce..:

Bolli, Roberto ; Perin, Emerson C ; Willerson, James T...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781291/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
10

Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induce..:

Bolli, Roberto ; Perin, Emerson C ; Willerson, James T...
qt9c54g4r1.  , 2020
Link: https://escholarship.org..
 
?
11

Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induce..:

Bolli, Roberto ; Perin, Emerson C ; Willerson, James T...
10.1016/j.jaccao.2020.09.001.  , 2020
Link: https://hdl.handle.net/1..
 
?
12

Evaluation of Cell Therapy on Exercise Performance and Limb..:

Perin, Emerson C ; Murphy, Michael P ; March, Keith L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388585/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
13

Effect of Transendocardial Delivery of Autologous Bone Marr..:

Perin, Emerson C ; Willerson, James T ; Pepine, Carl J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600947.  , 2012
Link: http://www.ncbi.nlm.nih...
 
?
14

Effect of the Use and Timing of Bone Marrow Mononuclear Cel..:

Traverse, Jay H ; Henry, Timothy D ; Pepine, Carl J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652242.  , 2012
Link: http://www.ncbi.nlm.nih...
 
?
15

Factors affecting the Turnaround Time for Manufacturing, Te..:

Richman, Sara ; Gee, Adrian P ; McKenna, David...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355200.  , 2012
Link: http://www.ncbi.nlm.nih...
 
1-15